Sally Pipes: “Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients”

A chaotic FDA is incompatible with a thriving, competitive market for medical discovery. Any effort to reform the agency must prioritize removing barriers and avoiding delays that keep safe, effective medicines from reaching patients.